Risk factors of postoperative major adverse cardiac events after radical cystectomy: implication of diastolic dysfunction

Sci Rep. 2019 Oct 1;9(1):14096. doi: 10.1038/s41598-019-50582-6.

Abstract

Radical cystectomy, which is a standard treatment of muscle invasive and high-grade non-invasive bladder tumour, is accompanied with high rates of postoperative complications including major adverse cardiac events (MACE). Diastolic dysfunction is associated with postoperative complications. We evaluated perioperative risk factors including diastolic dysfunction related with MACE within 6 months after radical cystectomy. The 546 patients who underwent elective radical cystectomy were included. Diastolic dysfunction was defined as early transmitral flow velocity (E)/early diastolic mitral annulus velocity (e') > 15. Logistic regression analysis, Kaplan-Meier survival analysis and log-rank test were performed. MACE within 6 months after radical cystectomy developed in 43 (7.9%) patients. MACE was related with female (odds ratio 2.546, 95% confidence interval 1.166-5.557, P = 0.019) and diastolic dysfunction (odds ratio 3.077, 95% confidence interval 1.147-8.252, P = 0.026). The 6-month mortality were significantly higher in the MACE group, and hospital stay and intensive care unit stay were significantly longer in the MACE group compared to the non-MACE group. Accordingly, preoperative diastolic dysfunction (E/e' > 15) was related with postoperative MACE and MACE was related with 6-month survival after radical cystectomy. These results suggest that preoperative diastolic dysfunction can provide useful information on postoperative complications.

MeSH terms

  • Aged
  • Amylases / physiology*
  • Cystectomy / adverse effects*
  • Cystectomy / mortality
  • Female
  • Heart Failure, Diastolic / etiology*
  • Heart Failure, Diastolic / mortality
  • Heart Failure, Diastolic / physiopathology
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Postoperative Complications / etiology*
  • Postoperative Complications / mortality
  • Risk Factors
  • Sex Factors
  • Survival Analysis
  • Urinary Bladder Neoplasms / surgery

Substances

  • Amylases